QuantLogix ← IVZ scorecard
📅 IVZ Earnings Preview
Invesco LTD
Next report (est.)
11/04/2026
Countdown
7 days
EPS growth YoY
+2633.3%
Revenue growth YoY
+20.5%
Options-implied earnings move
±7.5%
The at-the-money straddle prices a move to roughly $30.55 or $26.30 from $28.43 by 11/20/2026.
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
08/04/2026 ±4.1% +3.5% over-priced
05/05/2026 ±3.7% +3.0% over-priced
02/24/2026 ±3.8% +3.6% over-priced
11/04/2025 ±3.1% -1.4% over-priced
08/01/2025 ±2.5% -1.9% over-priced
04/28/2025 ±5.5% +0.1% over-priced
02/25/2025 ±2.8% -1.6% over-priced
10/29/2024 ±2.8% +0.2% over-priced
Across these reports, options implied an average ±3.5% move vs an actual average of 1.9% — the stock stayed inside the implied band 100% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q2 FY2026 $0.76 $1.8B $339M
Q1 FY2026 $0.51 $1.7B $219M
Q4 FY2025 — $1.7B $-900M
Q3 FY2025 $0.66 $1.6B $356M
Live 5-factor engine read: Neutral · 51/100 Full scorecard →
🤖 Pro runs a 10-agent AI debate on IVZ before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

Invesco LTD (IVZ) reports in 7 days, with the next report estimated for 11/04/2026. Across the last 8 reports, options priced an average ±3.5% earnings move while the stock actually moved 1.9% on average — the market has systematically over-priced IVZ's earnings risk. Fundamentals into the print: EPS up 2633.3% year-over-year, revenue up 20.5%. QuantLogix's live 5-factor engine currently reads IVZ as a neutral at 51/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →